NESINA ALOGLIPTIN 25MG 28TABS

Description

INCRESINA® is a dipeptidyl-peptidase-4 (DPP-4) inhibitor, indicated as a supplement to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in the following clinical conditions:

• As monotherapy in patients with inadequate glycemic control with diet and exercise.

• As an adjunct to metformin treatment.

• As an adjunct to treatment with a thiazolidinedione (TZD).

• As an adjunct to treatment with a sulfonylurea (SU).

• As an adjunct to insulin treatment.